(-)-gallocatechin gallate has been researched along with epigallocatechin gallate in 15 studies
| Studies ((-)-gallocatechin gallate) | Trials ((-)-gallocatechin gallate) | Recent Studies (post-2010) ((-)-gallocatechin gallate) | Studies (epigallocatechin gallate) | Trials (epigallocatechin gallate) | Recent Studies (post-2010) (epigallocatechin gallate) |
|---|---|---|---|---|---|
| 19 | 0 | 10 | 5,456 | 173 | 3,403 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, CY; Huang, SS; Yeh, SF | 1 |
| Backleh-Sohrt, M; Ekici, P; Leupold, G; Parlar, H | 1 |
| Brun, R; Lack, G; Perozzo, R; Rüedi, P; Scapozza, L; Tasdemir, D | 1 |
| Cai, L; Gochin, M | 1 |
| Corbo, C; Di Maggio, V; Hillier, S; Isaacs, CE; Jenkins, EC; Jia, JH; Rohan, L; Wen, GY; Xu, W | 1 |
| Cho, D; Cho, SY; Ham, M; Kim, JB; Lee, TR; Park, J; Shin, DW; Shin, ES; Shin, JM | 1 |
| Bisson, WH; Dashwood, RH; Larsen, CA | 1 |
| Fujiwara, K; Murakami, N; Tamura, S; Yoshihira, K | 1 |
| Adam, AT; Bhat, R; Gasiewicz, TA; Henry, EC; Lee, JJ; Rotella, DP | 1 |
| Adam, AT; Bhat, R; Deloison, G; Lee, JJ; Rotella, DP; Rouillé, Y; Séron, K | 1 |
| Golonko, A; Lazny, R; Lewandowski, W; Pienkowski, T; Roszko, M; Swislocka, R | 1 |
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Cao, W; Jian, Y; Ju, X; Li, H; Liang, C; Liu, H; Liu, Y; Ren, X; Tian, L; Wang, Y; Xie, X; Xin, L; Zhang, D; Zhao, Q | 1 |
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Araldi, GL; Hwang, YW | 1 |
4 review(s) available for (-)-gallocatechin gallate and epigallocatechin gallate
| Article | Year |
|---|---|
Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
Topics: Animals; Diet; Humans; Neoplasms; Phenols; Polyphenols; Proteasome Endopeptidase Complex; Ubiquitin | 2019 |
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
The development of Coronavirus 3C-Like protease (3CL
Topics: Antiviral Agents; Coronavirus 3C Proteases; Cysteine Endopeptidases; Humans; Peptidomimetics; Protease Inhibitors; Viral Nonstructural Proteins | 2020 |
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
11 other study(ies) available for (-)-gallocatechin gallate and epigallocatechin gallate
| Article | Year |
|---|---|
Effect of anthraquinone derivatives on lipid peroxidation in rat heart mitochondria: structure-activity relationship.
Topics: Animals; Anthraquinones; Antioxidants; Free Radical Scavengers; In Vitro Techniques; Lipid Peroxidation; Male; Mitochondria, Heart; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1995 |
Efficiency of foam fractionation for the enrichment of nonpolar compounds from aqueous extracts of plant materials.
Topics: Carotenoids; Chemical Fractionation; Chromatography, High Pressure Liquid; Citrus; Curcuma; Curcumin; Cyclohexenes; Daucus carota; Flavanones; Hesperidin; Molecular Structure; Plant Extracts; Tea; Terpenes; Water | 2005 |
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship | 2006 |
A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.
Topics: Anti-HIV Agents; Biological Assay; Dose-Response Relationship, Drug; Fluorescence; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Membrane Fusion; Molecular Weight; Peptides; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Reproducibility of Results; Thermodynamics | 2007 |
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
Topics: Animals; Catechin; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microscopy, Electron; Vero Cells; Virion; Virus Inactivation | 2008 |
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Catechin; Coenzymes; Glucosephosphate Dehydrogenase; Humans; Kinetics; Mice; Molecular Structure; NADP; Structure-Activity Relationship | 2008 |
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
Topics: Antineoplastic Agents; Camellia sinensis; Catechin; Cell Line, Tumor; Colonic Neoplasms; Drug Screening Assays, Antitumor; Flavonoids; Gallic Acid; Humans; Kinetics; Models, Molecular; Phenols; Polyphenols; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Structure-Activity Relationship | 2009 |
New inhibitors for expression of IgE receptor on human mast cell.
Topics: Anthocyanins; Anti-Allergic Agents; Catechin; Cell Line; Flavones; Flavonoids; Gene Expression; Humans; Hypersensitivity; Mast Cells; Receptors, IgE | 2010 |
Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors.
Topics: Biological Products; Catechin; Drug Discovery; HSP90 Heat-Shock Proteins; Structure-Activity Relationship | 2014 |
Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
Topics: Antiviral Agents; Catechin; Cell Survival; Dose-Response Relationship, Drug; Hepacivirus; Humans; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Internalization | 2014 |
Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
Topics: Catechin; Humans; Multiple Sclerosis; Phosphorylation; Polyphenols; Structure-Activity Relationship; Tea | 2022 |